Sign in
CompletedNo phase

Efficacy Comparison Between Primary Care Physicians' Independent Auscultation and AI-assisted Auscultation for Congenital Heart Disease Screening in Patient-enriched Populations: A Randomized Controlled Trial

Key facts

Who runs it
Kun Sun
Where
China2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
212 people enrolled
Started
10 Feb 2025
Ended
31 Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • AI-assisted auscultation
  • Independent auscultation
Record updated
7 April 2026

Who can take part

Age
Up to 18 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Age between 0 to 18 years, with no gender restrictions
  • Children who consent to undergo echocardiography to determine the presence or absence of congenital heart disease
  • Voluntary participation in this study and signing of an informed consent form

Who cannot take part

  • Age greater than 18 years
  • Children who are unable to undergo echocardiography or who do not cooperate with auscultation
  • Participants who cannot provide informed consent or are unwilling to comply with study requirements to provide medical data for further analysis and research

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In recent years, the application of artificial intelligence (AI) in the healthcare domain has witnessed a significant surge, with deep learning emerging as a potent force in the medical field. Deep learning algorithms possess the remarkable ability to automatically extract intricate features and patterns, thereby facilitating highly accurate heart sound recognition. Drawing on this technological advancement, Professor Sun Kun and his research team from Xinhua Hospital, in collaboration with numerous centers spanning across China, have been diligently investigating the development and application of AI-assisted heart sound recognition for congenital heart disease (CHD) screening.

Read full original descriptionShow less

Utilizing electronic stethoscopes to meticulously collect heart sounds, and harnessing AI algorithms to analyze extensive datasets comprising heart sounds from both children diagnosed with CHD and those who are healthy, the system has been trained to adeptly differentiate between normal and pathological murmurs. The current iteration of the system boasts an impressive accuracy and sensitivity rate of 90%.

This study is designed as a randomized controlled trial (RCT) to be conducted at Shanghai Xinhua Hospital and Qinghai Provincial Women and Children's Hospital. The primary objective is to demonstrate the superiority of AI-assisted primary care physicians in identifying CHD over primary care physicians working independently. This will be achieved by conducting a comparative analysis of the performance of AI-assisted physicians versus their unassisted counterparts, thereby substantiating the model's practical applicability. Through an ongoing process of refinement and widespread application, this pioneering research endeavors to empower a diverse range of medical professionals, including general practitioners, child health physicians, and non-cardiovascular specialists, with the transformative capabilities of AI-assisted electronic auscultation. The ultimate goal is to elevate the standard of pediatric care across the nation.

The 2 groups in the trial

  • Independent auscultationExisting treatment, for comparison
  • AI-assisted auscultationTreatment being tested

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
7 April 2026